CSL is on a winner with the first ever sa-mRNA vaccine.
https://www.businesswire.com/news/home/20231221709319/en/CSL-and-Arcturus-Therapeutics%E2%80%99-ARCT-154-Demonstrates-Non-Inferiority-to-Original-Strain-and-Superior-Immunogenicity-to-Omicron-BA.45-Variant-Compared-to-First-Generation-mRNA-Vaccine-Booster
News: CSL CSL and Arcturus Therapeutics' Arct-154 Demonstrates Non-Inferiority To Original Strain, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.50 |
Change
1.550(0.59%) |
Mkt cap ! $128.5B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $230.1M | 870.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $265.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.80 | 79 | 1 |
View Market Depth
| Last trade - 16.12pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |